ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Oct 05, 2022 19:56 JST
艾美疫苗公佈全球發售結果 每股H股發售股份發售價為16.16港元
H股股份將於2022年10月6日在香港交易所主板開始買賣
香港, Oct 05, 2022 - (ACN Newswire) - 按2021年批簽發量計(不包括COVID-19疫苗)，中國第二大疫苗公司艾美疫苗股份有限公司（「艾美疫苗」或「公司」，連同其附屬公司，統稱「集團」，股份代號：06660.HK），今天宣佈全球發售結果，每股發售股份定價為16.16港元，公司H股將於2022年10月6日（星期四）於香港聯合交易所有限公司（「聯交所」）主機板正式掛牌並進行買賣，每手買賣單位為200股H股。
公司國際配售已獲超額認購，所募資金計劃用於推進在研疫苗的研發及持續豐富疫苗管線、為建設新生產設施的資本開支提供資金，以及投入銷售及營銷活動。公司表示，通過十年的有機增長以及外部資源整合，艾美疫苗已經成為中國疫苗行業的主要參與者。正式登陸香港股票交易市場，是艾美疫苗發展史上的重要里程碑，為公司發展揭開嶄新一章。本次順利上市，體現了全球投資者對公司業務發展的信任和支持，為公司的長遠發展奠下厚實的基礎。展望未來，艾美疫苗將不斷加速在研管線的研發與商業化進程，成為世界級疫苗企業，持續為股東創造更大價值。
Sectors: BioTech, Healthcare & Pharm
Copyright ©2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
Dec 06, 2022 11:00 JST
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
Dec 06, 2022 11:00 JST
DOCOMO to Introduce Latest R&D and Technologies During "docomo Open House'23" Online Event
Dec 05, 2022 16:52 JST
Mitsubishi Power Receives 55MW Geothermal Power Plant Order from Pertamina
Dec 05, 2022 15:26 JST
Release of Mazda Integrated Report 2022
Dec 05, 2022 12:30 JST
Olympus Announces Launch of Olympus Asia Pacific Innovation Program
Dec 05, 2022 09:00 JST
Olympus Announces Launch of Olympus Asia Pacific Innovation Program
Dec 05, 2022 09:00 JST
Startups rapidly emerging from Central Japan - local entrepreneurs explain why
Dec 03, 2022 00:00 JST
Startups rapidly emerging from Central Japan - local entrepreneurs explain why
Dec 03, 2022 00:00 JST
Blockpass releases crypto's first Unhosted Wallet KYC
Dec 02, 2022 14:00 JST
TOYOTA GAZOO Racing Launches GR Corolla Sales Efforts with Lotteries in Japan
Dec 02, 2022 13:48 JST
DENSO Receives IEEE Corporate Innovation Award for Developing and Spreading Use of QR Code
Dec 02, 2022 11:29 JST
NEC and SINAI Technologies Collaborate to Create Pathways to Decarbonization
Dec 02, 2022 09:26 JST
Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium
Dec 01, 2022 20:09 JST
Honda Unveils Next-generation Technologies of Honda SENSING 360 and Honda SENSING Elite
Dec 01, 2022 19:01 JST
MHI Publishes Integrated Report "MHI Report 2022"
Nov 30, 2022 18:07 JST
Mitsubishi Heavy Industries Engineering to be Integrated into MHI
Nov 30, 2022 16:02 JST
NEC Orchestrating Future Fund, an Ecosystem-type CVC Fund, Completes Final Close for US$140 Million
Nov 30, 2022 15:15 JST
Mitsubishi Power to Upgrade Two Gas Turbines at Tuas Power to Achieve 16.9 kilo-tonnes of Carbon Emissions Reduction Annually
Nov 30, 2022 14:55 JST
ExxonMobil, Mitsubishi Heavy Industries Form Carbon Capture Technology Alliance
Nov 30, 2022 11:56 JST
More Latest Release >>